2014
DOI: 10.1016/j.bbagen.2014.04.012
|View full text |Cite
|
Sign up to set email alerts
|

Glycan specificity of a testis-specific lectin chaperone calmegin and effects of hydrophobic interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 40 publications
0
7
0
Order By: Relevance
“…There are several examples involving N-glycan biosynthesis during protein glycosylation. Calnexin is a lectin chaperone molecule that plays a key role in quality control of glycoprotein folding based on carbohydrate recognition of the Glc1Man9GlcNAc2 residue (16). ERGIC-53 and VIP36 are leguminous type (L-type) lectins that function as cargo receptors for trafficking of certain N-linked glycoproteins in secretory pathways of animal cells.…”
Section: Discussionmentioning
confidence: 99%
“…There are several examples involving N-glycan biosynthesis during protein glycosylation. Calnexin is a lectin chaperone molecule that plays a key role in quality control of glycoprotein folding based on carbohydrate recognition of the Glc1Man9GlcNAc2 residue (16). ERGIC-53 and VIP36 are leguminous type (L-type) lectins that function as cargo receptors for trafficking of certain N-linked glycoproteins in secretory pathways of animal cells.…”
Section: Discussionmentioning
confidence: 99%
“…The specificity of Calmegin, the testis-specific homolog of CNX/CRT,w as also revealed by synthetic glycans. [46] 3.2. Glucosidase II Glucosidase II (G-II) is ak ey enzyme in GPQC, which initiates both the entry into (Cleavage 1)a nd the exit from (Cleavage 2)t he CNX/CRT cycle ( Figure 7A).…”
Section: Chemical Synthesisofglycoproteinsmentioning
confidence: 99%
“…High-mannose-type glycans prepared by the chemo-enzymatic strategy have proven to be valuable in deciphering specificities of various CAPs in the ER. As a matter of fact, they have been employed in the analyses of malectin, [26] VIP36, [26] UGGT2, [27] calmegin, [28] and mannosidase I. [29] The renewed chemo-enzymatic approach will strengthen the basis for more comprehensive analysis of CAPs that act on high-mannose-type glycans.…”
Section: Substrate Specificity Of Gnt-i Toward M7-m3 Glycansmentioning
confidence: 99%